Navigation Links
PDL BioPharma Announces First Quarter 2009 Financial Results
Date:5/7/2009

nce as well as $0.9 million in software depreciation expense for which the software is now fully depreciated and is no longer in use.

Net income for the first quarter of 2009 was $37.5 million, or $0.23 per diluted share, compared with a net loss of $61.9 million in the same period of 2008, or a net loss of $0.42 per diluted share.

Net cash provided by operating activities was $27.7 million for the first quarter of 2009 as compared with net cash used in operating activities of $29.3 million for the first quarter of 2008. In addition to cash provided by operating activities in the three months ended March 31, 2009, we recognized $18.1 million of excess tax benefits from stock-based compensation, which is classified as a financing cash flow. At March 31, 2009, PDL had cash, cash equivalents, short-term investments and restricted cash of $193.2 million, compared with $147.5 million at December 31, 2008.

2009 Dividends

PDL previously announced that it would pay two dividends to its stockholders in 2009 of $0.50 per share. The first dividend, totaling $59.7 million, was paid on April 1, 2009 to all stockholders who owned shares of PDL on March 16, 2009. The second dividend will be paid on October 1, 2009 to stockholders of record on such date as to be determined by the Board of Directors at its June 2009 meeting.

Recent Developments

    -- Elected Frederick Frank and Jody Lindell to the Company's Board of
       Directors in March 2009 and subsequently designated Mr. Frank as Lead
       Director.

    -- As a result of the April 1, 2009 dividend payment, we announced
       An adjustment to the conversion rate for the Company's 2.75%
       Convertible Subordinated Notes due August 16, 2023 (the "2023 Notes").
       The conversion rate, as adjusted, is 123.715 shares of common stock per
       $1,000 principal amount of the 2023 Notes, effective 
'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sinobiopharma Secures Rights to Seven Key Patents
2. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
3. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
5. Helix BioPharma to Present at the BioFinance 2009 Conference
6. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
7. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
8. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
9. Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
10. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
11. Sinobiopharma, Inc. Appoints New Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Pittsburgh, PA (PRWEB) January 15, 2014 The ... Company, publisher of Food Safety Tech , an e-Journal ... has signed an agreement for the second year for the ... with Pittcon 2014. The partnership provides that the registration fee ...
(Date:1/15/2014)... Westlake Village, Calif. (PRWEB) January 15, 2014 ... cancer treatment and management through the genomic analysis of ... will offer Therapy Finder™, a web-based cancer decision support ... a reporting option with Cynvenio’s ClearID™ genomic test, Therapy ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... Reston, VA (PRWEB) January 15, 2014 ... education have continued their sponsorship of an annual competition ... interest in, and access to, innovative STEM study. The ... , TEAMS: Tests of Engineering Aptitude, Mathematics, and ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... MONICA, Calif., Oct. 9 Aida,Pharmaceuticals, Inc. ... China,s,leading pharmaceutical companies, today announced that the ... sale of Etimicin,sulfate throughout China. Aida expects ... to increase noticeably as sales efforts are,pursued ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... company, today announced that it intends to ... Food and Drug Administration,(FDA) for its innovative, ... "After reviewing the data from our recently ...
... Pharmaceutical and biotech,companies reach much greater and sustained ... and marketing, balancing therapeutic,innovation with commercial focus in ... companies to break down the walls that have ... strengths of both,talented medical researchers and skillful marketers. ...
Cached Biology Technology:Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 2Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 2Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 3Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 4Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 5Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 6Pharmaceutical Product Launch: Commercially Focused R&D Increases Drug's Market Potential 2
(Date:4/21/2014)... which is commonly used as a farm soil fertilizer, ... genes from the cows, gut bacteria. The findings, reported ... the American Society for Microbiology, hints that cow manure ... resistance genes that transfer to bacteria in the soils ... resistance (AR) genes have already been identified, but the ...
(Date:4/21/2014)... Dallas have received a federal grant to investigate ... of many everyday products might affect human health. ... and Dr. Rockford Draper, professor of molecular and ... from the National Institute of Environmental Health Sciences, ... track how multi-walled carbon nanotubes interact with human ...
(Date:4/21/2014)... Professor Lawrence Krauss was honored at the Academia ... to public understanding of science and for his ... The Academia Film Olomouc award for Outstanding Communication ... on April 19, in Olomouc, Czech Republic. , ... of science documentary films, and the largest such ...
Breaking Biology News(10 mins):Cow manure harbors diverse new antibiotic resistance genes 2Cow manure harbors diverse new antibiotic resistance genes 3Grant to fund research on possible cell contaminants 2Grant to fund research on possible cell contaminants 3Lawrence Krauss is honored at international festival of science documentary films 2Lawrence Krauss is honored at international festival of science documentary films 3
... (Edmonton) Two University of Alberta researchers have published a step ... harmful chemicals on commercial crops by developing plants that produce ... biologist Allen Good says the energy required to produce nitrogen ... a $100 billion a year. Good says that while they ...
... adelgid, has been marching north along the Appalachians, killing almost ... forests in Georgia, Tennessee, and Virginia. The pest recently arrived ... only extreme cold stops the adelgid. But now a ... "fungal microfactory" technology that promises to give forest managers and ...
... joint meeting of the International Ethological Conference (IEC) and ... more than 1,100 researchers from around the world for ... Included among the speakers will be one of ... head of the Department of Ethology at the Etvs ...
Cached Biology News:Forest fungus factory 2Behavior 2011 to draw global contingent of more than 1,100 animal researchers to IU next week 2